TY  - GEN
AU  - Bicakli,Derya Hopanci
AU  - Varol,Umut
AU  - Degirmenci,Mustafa
AU  - Tunali,Didem
AU  - Cakar,Burcu
AU  - Durusoy,Raika
AU  - Karaca,Burcak
AU  - Sanli,Ulus Ali
AU  - Uslu,Ruchan
TI  - Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315
SN  - 1477-092X
PY  - 2016///0405
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - adverse effects
KW  - Female
KW  - Humans
KW  - Metabolic Syndrome
KW  - chemically induced
N1  - Publication Type: Letter; Comment
UR  - https://doi.org/10.1177/1078155215585051
ER  -